Literature DB >> 21633930

Infectious serologies and autoantibodies in hepatitis C and autoimmune disease-associated mixed cryoglobulinemia.

Merav Lidar1, Noga Lipschitz, Nancy Agmon-Levin, Pnina Langevitz, Ori Barzilai, Maya Ram, Bat-Sheba Porat-Katz, Nicola Bizzaro, Jan Damoiseaux, Jan Willem Cohen Tervaert, Salvatore deVita, Stefano Bombardieri, Yehuda Shoenfeld.   

Abstract

Mixed cryoglobulinemia (MC) syndrome is an immune complex-mediated vasculitis characterized by the clinical triad of purpura, weakness, and arthralgias, the morbidity of which is mainly related to kidney and peripheral nervous system dysfunction as well as to the development of a secondary lymphoma (Ferri et al. Autoimmun Rev 7:114-120, 2007, Lidar et al. Ann N Y Acad Sci 1173:649-657, 2009, Trejo et al. Semin Arthritis Rheum 33:19-28, 2003). MC is associated with infectious and systemic disorders, principally autoimmune and lymphoproliferative diseases. Since the 1990s, a striking association (>90%) between MC and hepatitis C virus (HCV) infection has been established (Ferri and Bombardieri 2004; Pascual et al. J Infect Dis 162:569-570, 1990). However, information regarding the etiopathogenesis of HCV-negative MC is scant (Mascia et al. Dig Liver Dis 39:61-64, 2007). We hereby present our findings, as well as previously published data, regarding the presence of antibodies against infectious agents and autoantibodies in patients with MC in an attempt to establish novel associations which may shed light on the etiopathogenesis of this disease.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 21633930     DOI: 10.1007/s12016-011-8275-x

Source DB:  PubMed          Journal:  Clin Rev Allergy Immunol        ISSN: 1080-0549            Impact factor:   8.667


  68 in total

1.  Hepatitis C virus in patients with cryoglobulinemia type II.

Authors:  M Pascual; L Perrin; E Giostra; J A Schifferli
Journal:  J Infect Dis       Date:  1990-08       Impact factor: 5.226

2.  Entecavir to treat hepatitis B-associated cryoglobulinemic vasculitis.

Authors:  Masaru Enomoto; Takeshi Nakanishi; Takeshi Nakamishi; Masamitsu Ishii; Akihiro Tamori; Norifumi Kawada
Journal:  Ann Intern Med       Date:  2008-12-16       Impact factor: 25.391

3.  Absence of association between infectious agents and endothelial function in healthy young men.

Authors:  Paul Khairy; Stephane Rinfret; Jean-Claude Tardif; Richard Marchand; Stan Shapiro; James Brophy; Jocelyn Dupuis
Journal:  Circulation       Date:  2003-04-07       Impact factor: 29.690

4.  Exacerbation of peripheral neuropathy during alpha-interferon therapy in a patient with mixed cryoglobulinemia and hepatitis B virus infection.

Authors:  L La Civita; A L Zignego; F Lombardini; M Monti; G Longombardo; G Pasero; C Ferri
Journal:  J Rheumatol       Date:  1996-09       Impact factor: 4.666

Review 5.  Hepatitis C virus infection and autoimmunity.

Authors:  R W McMurray; K Elbourne
Journal:  Semin Arthritis Rheum       Date:  1997-02       Impact factor: 5.532

6.  Seroprevalence of Helicobacter pylori infection in inflammatory bowel disease: is Helicobacter pylori infection a protective factor?

Authors:  P O Väre; B Heikius; J A Silvennoinen; R Karttunen; S E Niemelä; J K Lehtola; T J Karttunen
Journal:  Scand J Gastroenterol       Date:  2001-12       Impact factor: 2.423

7.  Prevalence and risk factors for the presence of serum cryoglobulins in patients with chronic hepatitis C.

Authors:  M Cicardi; B Cesana; E Del Ninno; E Pappalardo; E Silini; A Agostoni; M Colombo
Journal:  J Viral Hepat       Date:  2000-03       Impact factor: 3.728

8.  Anti-extractable nuclear antigens (ENA) antibodies in patients with chronic hepatitis C before and after treatment with interferon.

Authors:  Katsuhisa Omagari; Kazuo Ohba; Yoshiko Kadokawa; Kenji Hayashida; Hajime Isomoto; Fuminao Takeshima; Yohei Mizuta; Ikuo Murata; Shigeru Kohno
Journal:  Autoimmunity       Date:  2003-08       Impact factor: 2.815

Review 9.  Role of infectious agents in systemic rheumatic diseases.

Authors:  H Amital; M Govoni; R Maya; P L Meroni; B Ori; Y Shoenfeld; A Tincani; F Trotta; P Sarzi-Puttini; F Atzeni
Journal:  Clin Exp Rheumatol       Date:  2008 Jan-Feb       Impact factor: 4.473

10.  Hematologic malignancies in patients with cryoglobulinemia: association with autoimmune and chronic viral diseases.

Authors:  Olga Trejo; Manuel Ramos-Casals; Armando López-Guillermo; Mario García-Carrasco; Jordi Yagüe; Ricard Cervera; Josep Font; Miguel Ingelmo
Journal:  Semin Arthritis Rheum       Date:  2003-08       Impact factor: 5.532

View more
  7 in total

1.  The challenge of treating orphan disease.

Authors:  Carlos Dias; Carlo Selmi
Journal:  Clin Rev Allergy Immunol       Date:  2014-12       Impact factor: 8.667

2.  Hepatitis C virus and its renal manifestations: a review and update.

Authors:  Nyan Latt; Nada Alachkar; Ahmet Gurakar
Journal:  Gastroenterol Hepatol (N Y)       Date:  2012-07

Review 3.  Epigenetics and Vasculitis: a Comprehensive Review.

Authors:  Paul Renauer; Patrick Coit; Amr H Sawalha
Journal:  Clin Rev Allergy Immunol       Date:  2016-06       Impact factor: 8.667

4.  Hepatitis C virus-host interactions: Etiopathogenesis and therapeutic strategies.

Authors:  Mohamed Hassan; Denis Selimovic; Abdelouahid El-Khattouti; Hanan Ghozlan; Youssef Haikel; Ola Abdelkader
Journal:  World J Exp Med       Date:  2012-04-20

Review 5.  Diagnostics and treatment of cryoglobulinaemia: it takes two to tango.

Authors:  Jan Damoiseaux; Jan Willem Cohen Tervaert
Journal:  Clin Rev Allergy Immunol       Date:  2014-12       Impact factor: 8.667

Review 6.  Autoimmune features in metabolic liver disease: a single-center experience and review of the literature.

Authors:  Koichi Tsuneyama; Hayato Baba; Kentaro Kikuchi; Takeshi Nishida; Kazuhiro Nomoto; Shinichi Hayashi; Shigeharu Miwa; Takahiko Nakajima; Yuko Nakanishi; Shinji Masuda; Mitsuhiro Terada; Johji Imura; Carlo Selmi
Journal:  Clin Rev Allergy Immunol       Date:  2013-08       Impact factor: 8.667

Review 7.  Extrahepatic manifestations and autoantibodies in patients with hepatitis C virus infection.

Authors:  Takashi Himoto; Tsutomu Masaki
Journal:  Clin Dev Immunol       Date:  2012-09-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.